These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10221351)

  • 61. Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits.
    Weckler N; Leitzbach D; Kalinowski L; Malinski T; Busch AE; Linz W
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):191-6. PubMed ID: 14608526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The effect of captopril and valsartan on preventing the formation of atherosclerotic plaque].
    Lu YS; Lei XY; DI J; Huang ST; Li JM
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):425-7. PubMed ID: 16008853
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone.
    Chen S; Noguchi Y; Izumida T; Tatebe J; Katayama S
    J Hypertens; 1996 Nov; 14(11):1325-30. PubMed ID: 8934361
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A paradoxical increase in circulating ACE (angiotensin converting enzyme) activity after long-term administration of alacepril (ACE inhibitor).
    Nishida S; Matsuki M; Sumitomo S; Kawai Y; Yoneda M
    Horm Metab Res; 1997 Mar; 29(3):153-4. PubMed ID: 9137988
    [No Abstract]   [Full Text] [Related]  

  • 65. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
    Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
    J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The inhibitory effect of alacepril, an angiotensin-converting enzyme inhibitor, on endothelial inflammatory response induced by oxysterol and TNF-alpha.
    Shimozawa M; Naito Y; Manabe H; Uchiyama K; Katada K; Kuroda M; Nakabe N; Yoshida N; Yoshikawa T
    Redox Rep; 2004; 9(6):354-9. PubMed ID: 15720832
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Treatment of latent diabetic nephropathy with ACE inhibitor alacepril].
    Hashimoto T
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):549-56. PubMed ID: 1920934
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of cadmium and captopril on serum angiotensin converting enzyme activity in rats.
    Puri VN
    Indian Heart J; 1997; 49(3):297-9. PubMed ID: 9291654
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.
    Honda Y; Minato H; Fujitani B; Masuda Y; Hosoki K
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):699-706. PubMed ID: 9542720
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of ACE inhibitors on atheroma formation is potentiated by association with a calcium channel blocker. A biochemical and ultrastructural study.
    Raicu M; Pojoga L; Simionescu N; Simionescu M
    J Submicrosc Cytol Pathol; 1997 Jul; 29(3):317-28. PubMed ID: 9267040
    [TBL] [Abstract][Full Text] [Related]  

  • 71. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 2nd communication: Effects on central nervous and sensory systems and on the other functions.
    Matsuno Y; Hori H; Oka M; Nakamura H; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):62-8. PubMed ID: 3513778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
    Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of long-term treatment with angiotensin-converting enzyme inhibitor on angiotensin II and prostacyclin release from mesenteric arteries in spontaneously hypertensive rats.
    Ito M; Soma M; Izumi Y; Kanmatsuse K
    Prostaglandins Leukot Essent Fatty Acids; 1995 Nov; 53(5):359-63. PubMed ID: 8596776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K; Nambu K; Fujii T; Takeyama K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):52-4. PubMed ID: 3006711
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.
    Onoyama K; Hirakata H; Tsuruda H; Ohchi N; Tomooka S; Motomura K; Omae T; Hayashi K; Fujishima M
    Clin Pharmacol Ther; 1985 Oct; 38(4):462-8. PubMed ID: 3899460
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure.
    Nonoguchi H; Kiyama S; Kitamura K; Naruse M; Tomita M; Tazoe N; Tajiri M; Nakayama Y; Kohda Y; Inoue T; Tomita K
    Hypertens Res; 2008 Jan; 31(1):29-36. PubMed ID: 18360015
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.
    Hayek T; Attias J; Coleman R; Brodsky S; Smith J; Breslow JL; Keidar S
    Cardiovasc Res; 1999 Dec; 44(3):579-87. PubMed ID: 10690290
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril.
    Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y
    Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Angiotensin-Converting Enzyme in Smooth Muscle Cells Promotes Atherosclerosis-Brief Report.
    Chen X; Howatt DA; Balakrishnan A; Moorleghen JJ; Wu C; Cassis LA; Daugherty A; Lu H
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1085-9. PubMed ID: 27055902
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of the angiotensin-converting enzyme inhibitor alacepril on ventricular function and beta-adrenoceptor number in rabbits with aortic regurgitation.
    Yoshikawa T; Handa S; Nagami K; Suzuki M; Wainai Y; Minami T; Suzuki K; Kitazawa S
    Jpn Heart J; 1995 Jan; 36(1):91-100. PubMed ID: 7760517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.